Mobile |
Deutsch |
Español |
Français |
日本語 |
한국어 |
Português |
Русский |
中文 |
العربية |
PATENTSCOPE
Search International and National Patent Collections
Options
Query
Result
Interface
Office
Translate
«
↓
»
Query Language
All
English
Hebrew
Korean
Spanish
Vietnamese
Arabic
Estonian
Indonesian
Polish
Swedish
Chinese
French
Italian
Portuguese
Swedish
Danish
German
Japanese
Russian
Thai
Stem
Sort by:
Relevance
Pub Date Desc
Pub Date Asc
App Date Desc
App Date Asc
List Length
10
50
100
200
Result List Language
Query Language
Vietnamese
German
Italian
Arabic
Swedish
English
Hebrew
Japanese
Polish
Estonian
Spanish
Portuguese
Russian
Danish
Indonesian
Korean
French
Chinese
Swedish
Thai
Displayed Fields
Application Number
Abstract
Int. Class
Inventor Name
Publication Date
Applicant Name
Image
Chart/Graph
Table
Graph
Group by
None
IPC code
Inventors
Publication Dates
Offices of NPEs
Applicants
Filing Dates
Countries
No of Items/Group
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
Download Fields
NPEs
Default Search Form
Simple
Advanced Search
Field Combination
Browse by Week (PCT)
Cross Lingual Expansion
Translator
Default Tab Search Form
Front Page
Any Field
Full Text
ID/Numbers
IPC
Names
Dates
Interface Language
English
Deutsch
Français
Español
日本語
中文
한국어
Português
Русский
Skins
Default
Plain
Blue_Sky
Classic
Deep_Marine
Emerald_Town
Japan_Cherry
Ruby
Wine
Multiple Windows Interface
Tooltip Help
IPC Tooltip Help
Office:
All
All
PCT
Africa
ARIPO
Egypt
Kenya
Morocco
Tunisia
South Africa
Americas
United States of America
Canada
LATIPAT
Argentina
Brazil
Chile
Colombia
Costa Rica
Cuba
Dominican Rep.
Ecuador
El Salvador
Guatemala
Honduras
Mexico
Nicaragua
Panama
Peru
Uruguay
Asia-Europe
Australia
Bahrain
China
Denmark
Estonia
Eurasian Patent Office
European Patent Office
France
Germany
Germany(DDR data)
Israel
Japan
Jordan
Portugal
Russian Federation
Russian Federation(USSR data)
Saudi Arabia
United Arab Emirates
Spain
Republic of Korea
India
United Kingdom
Georgia
Asean
Singapore
Viet Nam
Indonesia
Cambodia
Malaysia
Brunei Darussalam
Philippines
Thailand
WIPO translate (Wipo internal translation tool)
Search
Simple
Advanced Search
Field Combination
Cross Lingual Expansion
Browse
Browse by Week (PCT)
Gazette Archive
Download National Phase Entries
Sequence listing
IPC Green Inventory
Portal to patent registers
Translate
WIPO Translate
WIPO Pearl
Options
Sort
Graph
Show Options
News
PATENTSCOPE News
Login
Login
Account Sign Up
Help
How to Search
User Guide PATENTSCOPE
User Guide: Cross Lingual Expansion
User Guide: ChemSearch
Query Syntax
Fields Definition
Country Code
Data Coverage
PCT applications
PCT national phase entry
National collections
Global Dossier public
FAQ
Feedback&Contact
INID codes
Kind codes
Tutorials
About
Overview
Terms And Conditions
Disclaimer
Home
IP Services
PATENTSCOPE
Machine translation
Wipo Translate
Arabic
German
English
Spanish
French
Japanese
Korean
Portuguese
Russian
Chinese
Google Translate
Bing/Microsoft Translate
Baidu Translate
Arabic
English
French
German
Spanish
Portuguese
Russian
Korean
Japanese
Chinese
...
Italian
Thai
Cantonese
Classical Chinese
1. (WO2001004320) ATTENUATED HUMAN-BOVINE CHIMERIC PARAINFLUENZA VIRUS (PIV) VACCINES
PCT Biblio. Data
Description
Claims
National Phase
Notices
Drawings
Documents
«
↓
»
Latest bibliographic data on file with the International Bureau
PermaLink
PermaLink
Bookmark
Pub. No.:
WO/2001/004320
International Application No.:
PCT/US2000/017066
Publication Date:
18.01.2001
International Filing Date:
16.06.2000
Chapter 2 Demand Filed:
10.01.2001
IPC:
C07K 14/115
(2006.01)
C
CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005
from viruses
08
RNA viruses
115
Paramyxoviridae, e.g. parainfluenza virus
Applicants:
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
[US/US]; Suite 325, 6011 Executive Boulevard, Rockville, MD 20852 (US)
(For All Designated States Except US)
.
SCHMIDT, Alexander, C.
[DE/US]; (US)
(For US Only)
.
SKIADOPOULOS, Mario, H.
[US/US]; (US)
(For US Only)
.
COLLINS, Peter, L.
[US/US]; (US)
(For US Only)
.
MURPHY, Brian, R.
[US/US]; (US)
(For US Only)
.
BAILLY, Jane, E.
[CA/CA]; (CA)
(For US Only)
.
DURBIN, Anna, P.
[US/US]; (US)
(For US Only)
Inventors:
SCHMIDT, Alexander, C.
; (US).
SKIADOPOULOS, Mario, H.
; (US).
COLLINS, Peter, L.
; (US).
MURPHY, Brian, R.
; (US).
BAILLY, Jane, E.
; (CA).
DURBIN, Anna, P.
; (US)
Agent:
KING, Jeffrey, J.
; Townsend and Townsend and Crew LLP, 8th floor, Two Embarcadero Center, San Francisco, CA 94111-3834 (US)
Priority Data:
60/143,134
09.07.1999
US
Title
(EN)
ATTENUATED HUMAN-BOVINE CHIMERIC PARAINFLUENZA VIRUS (PIV) VACCINES
(FR)
VACCINS ATTENUES DE VIRUS CHIMERES DE PARAINFLUENZA HUMAIN-BOVIN (PIV)
Abstract:
(EN)
Chimeric human-bovine parainfluenza viruses (PIVs) are infectious and attenuated in humans and other mammals and useful individually or in combination in vaccine formulations for eliciting an anti-PIV immune response. Also provided are isolated polynucleotide molecules and vectors incorporating a chimeric PIV genome or antigenome which includes a partial or complete human or bovine PIV 'background' genome or antigenome combined or integrated with one or more heterologous gene(s) or genome segment(s) of a different PIV. Chimeric human-bovine PIV of the invention include a partial or complete 'background' PIV genome or antigenome derived from or patterned after a human or bovine PIV virus combined with one or more heterologous gene(s) or genome segment(s) of a different PIV virus to form the human-bovine chimeric PIV genome or antigenome. In certain aspects of the invention, chimeric PIV incorporate a partial or complete human PIV background genome or antigenome combined with one or more heterologous gene(s) or genome segment(s) from a bovine PIV, whereby the resultant chimeric virus is attenuated by virtue of host-range restriction. In alternate embodiments, human-bovine chimeric PIV incorporate a partial or complete bovine PIV background genome or antigenome combined with one or more heterologous gene(s) or genome segment(s) from a human PIV gene that encode a human PIV immunogenic protein, protein domain or epitope, for example encoded by PIV HN and/or F glycoprotein gene(s) or genome segment(s). Human-bovine chimeric PIV of the invention are also useful as vectors for developing vaccines against other pathogens. A variety of additional mutations and nucleotide modifications are provided within the human-bovine chimeric PIV of the invention to yield desired phenotypic and structural effects.
(FR)
La présente invention concerne des virus chimères de parainfluenza humain-bovin (PIV) infectieux et atténués chez l'homme et chez d'autres mammifères et qui sont utiles individuellement ou en combinaison dans des formulations de vaccins afin de provoquer une réponse immune anti-PIV. Elle concerne aussi des molécules de polynucléotide isolé ainsi que des vecteurs incorporant un génome ou un antigénome de PIV chimère qui comprend un génome ou un antigénome 'd'arrière plan' de PIV bovin ou humain partiel ou complet, combiné ou intégré à un ou plusieurs gènes ou à des segments de génome hétérologues d'un PIV différent. Le PIV chimère humain-bovin comprend un génome ou un antigénome d'arrière plan' de PIV partiel ou complet dérivé ou configuré d'après un virus PIV humain ou bovin combiné à un ou plusieurs gènes ou segments de génome hétérologues d'un virus PIV différent afin de former un génome ou un antigénome de PIV chimère humain-bovin. Dans certaines réalisations de l'invention, le PIV chimère comprend un génome ou un antigénome d'arrière plan de PIV humain partiel ou complet combiné à un ou plusieurs gènes ou segments de génome hétérologues provenant d'un PIV bovin, permettant au virus chimère résultant d'être atténué en raison d'une restriction du spectre d'activité. Dans d'autres réalisations, un PIV chimère humain-bovin incorpore un génome ou un antigénome d'arrière plan partiel ou complet combiné avec un ou plusieurs gènes ou segments de génome hétérologues provenant d'un gène de PIV humain qui code pour une protéine, un domaine de protéine ou un épitope immunogène de PIV humain, par exemple, codés par des gènes ou des segments de génome de PIV HN et/ou de glycoprotéine F. Le PIV chimère humain-bovin de l'invention est aussi utile comme vecteur destiné à développer des vaccins contre d'autres pathogènes. L'invention concerne aussi une variété de mutations supplémentaires et de modifications de nucléotides dans le PIV chimère humain-bovin afin d'obtenir des effets phénotypiques et structuraux recherchés.
Designated States:
AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language:
English (
EN
)
Filing Language:
English (
EN
)